Table 2.
List of the cell antigens used together with the molecular function and reported expression.
| Antigen | Other Name | Function | Expression | Reference |
|---|---|---|---|---|
| CD31 | PECAM-1 | Cell Adhesion, Angiogenesis | Endothelial Cells Glioma cancer stem cells |
(35) |
| CD34 | Hematopoietic Progenitor Antigen |
Cell Adhesion | Progenitor Cells Cancer Stem Cells Mesenchymal-like Cells |
(36) |
| CD63 | Tetraspanin-30 | Cell Receptor; IntegrinActivation and Signaling |
Cancer Exosomes | (37) |
| CD36 | Coll-1 Receptor | Angiogenesis, Cell Receptor | Endothelial Cells Cancer stem cells |
(38, 39) |
| CD29 | Integrin β-1 | Cell Receptor | Cancer Cells | (40–42) |
| CD90 | Thy-1 | Cell-Cell/Cell-Ligand Interaction |
Mature Neurons Mesenchymal Cancer Stem Cells |
(43, 44) |
| CD140α | Platelet-Derived Growth Factor; PDGFRα | RTK involved in Proliferation, Survival and Migration |
Widely Expressed in Brain Cancer Cells | (36, 45, 46) |
| CD49c | Integrin α-3 | Cell Receptor | Cancer Cells | (40) |
| CD56 | N-CAM1 | Cell Adhesion | Neural Lineage Glioma Cancer Stem Cells |
(36, 47, 48) |
| CD61 | Integrin β-3 | Cell Receptor | Cancer Cells | (46, 49) |
| GFAP | Glial Fibrillary Acid Protein |
Mechanical and Cell Strength | Astrocytes Glioma Cells |
(46) |
| Nestin | – | Survival and Proliferation |
CNS Stem Cells | (41, 46, 50, 51) |
| Musashi-1 | RNA-binding protein |
mRNA Expression Regulation |
CNS Stem Cells | (51) |
| H3.3G34R | – | Histone Mutation | DHG-G34 | (52) |
| H3K27M | – | Histone Mutation | DMG-K27, pilocytic astrocytoma, and glioneuronal tumors | (53) |